ad image

United Therapeutics

1 / 1
United Therapeutics: Enabling Inspiration
FDA Approval

United Therapeutics Announces FDA Approval and Launch of Tyvaso for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

United Therapeutics: Enabling Inspiration

PR-M04-21-003Apr 02, 2021
United Therapeutics Corporation
3D Bioprinting

CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

United Therapeutics Corporation

PR-M10-18-NI-095-3497Oct 26, 2018
United Therapeutics Corporation
FDA Approval

United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®

United Therapeutics Corporation

PR-M08-18-NI-016Aug 06, 2018
1 / 1